michael_fowlerAll are welcome to an invited seminar by Dr. Michael Fowler, Process Engineer Principal Transdermal Development, ACTAVIS. The title is: “Process Engineering in the Pharmaceutical Industry” The seminar will be from 10:45 to 11:35 a.m. on Tuesday February 17, 2015 in WEB L104.

Abstract The role of a process engineer in the pharmaceutical industry is complex and dynamic since he/she is responsible for various lifecycle stages of product development, including early R&D support, product and process design, raw material evaluation, commercial scale-up, technology transfer and commercial support. She/he is also responsible for documentation and presentation of technical work to management and regulatory agencies, including justifying in scientific and economical terms the approaches taken to perform such tasks. In an increasingly aggressive regulatory environment, high quality and quantity of work is expected with fewer resources. Innovation, creativity and intelligence is the goal of any engineer, and the combination of all three are especially difficult to implement in generic pharmaceutical products. The scope of this seminar will be to introduce briefly the role of the pharmaceutical process engineer.

Short Biography Michael Fowler is a Process Engineer Principal in the Transdermal Development division of Actavis in Research Park, Salt Lake City, Utah. He is responsible for a variety of research and development, scale-up and technology transfer activities of branded and generic semi-solid and liquid products. Michael has helped create Quality by Design and Process Analytical Technology guidance for projects in development phases. He has more than 12 years of experience in formulation and process development in transdermal and topical drug delivery technologies. Michael graduated from the University of Utah with a Bachelor’s Degree in Materials Science and Engineering and Master’s Degree of Business and Administration in product development.